Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Sumitomo Chemical Co ( (JP:4005) ) has issued an update.
Sumitomo Chemical Co. reported variances in the non-consolidated financial results of its subsidiaries for fiscal years 2024 and 2023. Sumitomo Pharma Co., Ltd. saw significant improvements in net sales and income due to increased sales in North America and China, alongside reduced expenses. Taoka Chemical Co., Ltd. experienced growth in sales and income driven by higher sales of resin raw materials and cost-cutting measures. The overall impact on Sumitomo Chemical’s consolidated financial forecast is considered immaterial.
The most recent analyst rating on (JP:4005) stock is a Hold with a Yen370.00 price target. To see the full list of analyst forecasts on Sumitomo Chemical Co stock, see the JP:4005 Stock Forecast page.
More about Sumitomo Chemical Co
Sumitomo Chemical Co. operates in the chemical industry, focusing on pharmaceuticals and chemical products. Its primary subsidiaries include Sumitomo Pharma Co., Ltd., which is involved in the pharmaceutical sector, and Taoka Chemical Co., Ltd., which specializes in chemical products like resin raw materials.
Average Trading Volume: 11,265,629
Technical Sentiment Signal: Sell
Current Market Cap: Yen585.5B
For detailed information about 4005 stock, go to TipRanks’ Stock Analysis page.